Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Cash from Investing Activities: 2019-2024

Historic Cash from Investing Activities for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to -$1.6 million.

  • MDxHealth's Cash from Investing Activities rose 129.58% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year increase of 88.30%. This contributed to the annual value of -$1.6 million for FY2024, which is 58.38% up from last year.
  • MDxHealth's Cash from Investing Activities amounted to -$1.6 million in FY2024, which was up 58.38% from -$3.9 million recorded in FY2023.
  • In the past 5 years, MDxHealth's Cash from Investing Activities registered a high of -$537,000 during FY2020, and its lowest value of -$29.0 million during FY2022.
  • Over the past 3 years, MDxHealth's median Cash from Investing Activities value was -$3.9 million (recorded in 2023), while the average stood at -$11.5 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first crashed by 3,181.13% in 2022, then skyrocketed by 86.46% in 2023.
  • MRY analysis of 5 years shows MDxHealth's Cash from Investing Activities stood at -$537,000 in 2020, then tumbled by 64.80% to -$885,000 in 2021, then crashed by 3,181.13% to -$29.0 million in 2022, then surged by 86.46% to -$3.9 million in 2023, then surged by 58.38% to -$1.6 million in 2024.
  • Its last three reported values are -$1.6 million in FY2024, -$3.9 million for FY2023, and -$29.0 million during FY2022.